Watch this on-demand webcast of a live CCO symposium where hemophilia experts discuss optimizing management of patients with hemophilia A, including factor and nonfactor replacement therapies, patient barriers, and managing comorbidities.
Factor replacement therapies and newer nonfactor agents offer the ability to tailor therapy for individual patients with hemophilia A. Additional therapies in late-stage development are poised to further alter the treatment landscape. Read an expert’s thoughts on how these new therapies might fit into the existing treatment paradigms in hemophilia A.
In this podcast episode, listen to Miguel A. Escobar, MD; Mark Reding, MD; and Guy A. Young, MD, answer questions from a healthcare professional audience related to the use of current and emerging treatments for patients with hemophilia A.
Download this PDF summary transcript of experts’ answers to questions posed during a live symposium on hemophilia A management.
Download these slides from a live webinar for expert guidance on using factor replacement therapy to improve clinical outcomes for patients with hemophilia A.
Download this slideset to learn more about the latest evidence on personalizing nonfactor therapy to optimize outcomes for patients with hemophilia A.
Download this slideset to learn more about strategies to mitigate complications associated with factor replacement therapy and comorbidities in patients with hemophilia A.
Download this summary slideset from a live webinar for expert guidance on optimizing factor replacement therapy, incorporating nonfactor therapy, and addressing adherence and comorbidities to improve clinical outcomes for patients with hemophilia A.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.